Welby Inc. logo

Welby Inc. (4438)

Market Closed
13 Aug, 06:00
JPX JPX
¥
259. 00
+3
+1.1719%
¥
2.45B Market Cap
- P/E Ratio
- Div Yield
9,600 Volume
- Eps
¥ 256
Previous Close
Add Transaction
Day Range
255 261
Year Range
231 558
Want to track 4438 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4438 closed today higher at ¥259, an increase of 1.1719% from yesterday's close, completing a monthly increase of 7.9167% or ¥19. Over the past 12 months, 4438 stock lost -8.8028%.
4438 is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Welby Inc. has completed 1 stock splits, with the recent split occurring on Oct 02, 2019.
The company's stock is traded on one exchange.

4438 Chart

People also search for

Nagaoka International Corp.
¥ 1,400
-1.4778%
Advantage Risk Management Co., Ltd.
¥ 525
+4.1667%
Makuake Inc.
¥ 869
-0.5721%
Yutaka Trusty Securities Co., Ltd.
¥ 2,082
+0.1443%
Sanrin Co., Ltd.
¥ 805
-0.6173%

Welby Inc. (4438) FAQ

What is the stock price today?

The current price is ¥259.00.

On which exchange is it traded?

Welby Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4438.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.45B.

Has Welby Inc. ever had a stock split?

Welby Inc. had 1 splits and the recent split was on Oct 02, 2019.

Welby Inc. Profile

Insurance Industry
Financials Sector
Mr. Takeru Hiki CEO
JPX Exchange
JP3155410008 ISIN
Japan Country
44 Employees
- Last Dividend
2 Oct 2019 Last Split
- IPO Date

Overview

Welby Inc. is a pioneering entity in the digital health landscape, focusing on the provision of innovative health solutions to facilitate effortless access to medical care services for patients. Since its inception in 2011, the company has established its headquarters in Tokyo, Japan. Welby Inc. is renowned for its comprehensive range of services that cater to various health concerns including chronic illnesses, mental health issues, and rare diseases. Beyond direct health services, the company extends its expertise into the medical data survey sector and boasts the operation of user-centered apps, web services, and advanced data management systems.

Products and Services

  • Diabetes Mellitus: Development of digital tools aimed at improving the lives of diabetes patients through remote monitoring, personalized care plans, and data-driven insights to manage their condition effectively.
  • Lifestyle Related Disease: Offering platforms that assist in the prevention and management of diseases caused by lifestyle factors through educational content, habit tracking, and intervention programs.
  • Mental Illness: Creating accessible mental health services that users can reach online for psychological support, including therapy and counseling options, along with tools for stress and anxiety management.
  • Autoimmune Disease: Delivery of specialized solutions for patients suffering from autoimmune diseases, facilitating remote consultations, and the tracking of symptoms to tailor treatment approaches.
  • Neurological Disease: Providing technology-enabled support for individuals with neurological conditions, encompassing symptom monitoring, cognitive exercises, and coordination with healthcare providers for optimal care.
  • Rare Disease: Tailoring digital platforms to meet the unique needs of patients with rare diseases, offering them a network for support, information on treatment options, and access to specialists.
  • Oncology: Support for cancer patients through digital services that offer information on disease management, treatment options, and connecting patients with oncology experts.
  • Pain: Developing solutions for pain management that include educational resources, tracking tools for pain levels, and integration with therapeutic programs.
  • Medical Data Survey Business: Engaging in the collection, analysis, and reporting of medical data to contribute to healthcare research and improvement of patient care services.
  • Apps, Web Services, and Data Management: Operating a suite of applications and web services designed to enhance the patient healthcare experience, integrated with a robust data management system to ensure privacy and security of patient information.

Contact Information

Address: Kanden Real Estate Yaesu Building
Phone: 81 3 6206 2937